Back to all opportunities
Martin and Harris Laboratories Ltd
Pharmaceutical and biotechnology medium risk
Is a leading Indian pharmaceutical company specializing in research-driven drug development and finished dosage form manufacturing. With R&D in Gurugram and GMP-certified, WHO-approved plants in Roorkee and Himachal Pradesh, they focus on gynecology, urology, gastroenterology, and pain management.
Investment Details
- Price per share
- ₹850
- Minimum lot size
- 250 shares
- Minimum investment
- ₹2,12,500
- Face value
- ₹10
Risk Assessment
medium Risk
Moderate volatility, growth stage company
Unlisted shares are high-risk investments. Past performance does not guarantee future results. Invest only what you can afford to lose.